Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydrophobic small-molecule guest compounds refer to a broad class of chemical entities characterized by their low affinity for water and high affinity for non-polar environments. In the context of pharmacology and supramolecular chemistry, these molecules act as 'guests' that reside within the cavities of 'host' molecules, such as cyclodextrins, micelles, or macrocyclic containers (Lehn, J. M., Supramolecular Chemistry, 1995). This interaction is primarily driven by hydrophobic effects, van der Waals forces, and hydrogen bonding rather than covalent linkages. This term does not describe a specific biological receptor, enzyme, or signaling protein, but rather a physical-chemical property shared by many therapeutic agents (Cragg, P. J., Supramolecular Chemistry: From Biological Inspiration to Biomedical Applications, 2010). Consequently, it is not a therapeutic target in the traditional sense; instead, it represents a category of molecules that often require specialized delivery systems to ensure efficacy. Many drugs, such as certain steroids or anti-cancer agents, fall into this category and face significant challenges related to poor aqueous solubility and low bioavailability. Understanding the interaction between these guest compounds and their delivery vehicles is crucial for optimizing the pharmacokinetic profile and therapeutic index of lipophilic drugs.
Not applicable as this refers to a chemical classification rather than a biological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydrophobic small-molecule guest compounds.